Prostate-specific membrane antigen (PSMA) [52] is a type II transmembrane protein, and PSMA expression has been reported in benign prostatic hyperplasia and increased to higher lever in high-grade prostatic intraepithelial neoplasia and prostatic adenocarcinoma [53]. The gene discussed is FOLH1; the disease is prostate intraepithelial neoplasia.